Company / AR per Share
Veracyte, Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.57
FY2025
5-year range
$0.56 / $0.71
FY2021-FY2025
Trend
-9.6%
vs FY2024
Sector context
#124 of 141
Health Care
What the data says
Veracyte, Inc.'s ar per share of $0.57 is lower than 88% of companies in the Health Care sector (FY2025). AR per Share has fluctuated over the past 10 years, ranging from $0.32 in FY2016 to $0.71 in FY2021.
Based on SEC 10-K filings.
0.57 in FY2025 with a 5-year CAGR of +9.1%.
Improved from $0.56 to $0.57 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -2.5%
- 5-Year CAGR
- +9.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 141This company $0.57 Sector average $11.78
▼
-95.1% below sector average
Key checks
Key Insights
- In FY2025, ar per share decreased 9.6% year-over-year.
- Ranks #124 out of 141 companies in the Health Care sector.
- Peak ar per share was recorded in FY2021.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.57 | -9.6% |
| FY2024 | $0.64 | +13.2% |
| FY2023 | $0.56 | -9.3% |
| FY2022 | $0.62 | -13.1% |
| FY2021 | $0.71 | +91.5% |
| FY2020 | $0.37 | -21.4% |
| FY2019 | $0.47 | +21.3% |
| FY2018 | $0.39 | +3.6% |
| FY2017 | $0.38 | +19.1% |
| FY2016 | $0.32 | +103.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026